These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 33777778)

  • 1. Mutational Profile and Clonal Evolution of Relapsed/Refractory Diffuse Large B-Cell Lymphoma.
    Lee B; Lee H; Cho J; Yoon SE; Kim SJ; Park WY; Kim WS; Ko YH
    Front Oncol; 2021; 11():628807. PubMed ID: 33777778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific Mutation Predict Relapse/Refractory Diffuse Large B-Cell Lymphoma.
    Wang J; Tian L; Zhang W; Tang S; Zhao W; Guo Y; Wu C; Lin Y; Ke X; Jing H
    J Blood Med; 2024; 15():407-419. PubMed ID: 39279878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations or copy number losses of CD58 and TP53 genes in diffuse large B cell lymphoma are independent unfavorable prognostic factors.
    Cao Y; Zhu T; Zhang P; Xiao M; Yi S; Yang Y; Li Q; Ling S; Wang Y; Gao L; Zhu L; Wang J; Wang N; Huang L; Zhang P; Zhai Q; Qiu L; Zhou J
    Oncotarget; 2016 Dec; 7(50):83294-83307. PubMed ID: 27825110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas.
    Morin RD; Assouline S; Alcaide M; Mohajeri A; Johnston RL; Chong L; Grewal J; Yu S; Fornika D; Bushell K; Nielsen TH; Petrogiannis-Haliotis T; Crump M; Tosikyan A; Grande BM; MacDonald D; Rousseau C; Bayat M; Sesques P; Froment R; Albuquerque M; Monczak Y; Oros KK; Greenwood C; Riazalhosseini Y; Arseneault M; Camlioglu E; Constantin A; Pan-Hammarstrom Q; Peng R; Mann KK; Johnson NA
    Clin Cancer Res; 2016 May; 22(9):2290-300. PubMed ID: 26647218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mutational profile of immune surveillance genes in diagnostic and refractory/relapsed DLBCLs.
    Nesic M; Sønderkær M; Brøndum RF; El-Galaly TC; Pedersen IS; Bøgsted M; Dybkær K
    BMC Cancer; 2021 Jul; 21(1):829. PubMed ID: 34275438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Landscape of Relapsed and Refractory Diffuse Large B-Cell Lymphoma: A Systemic Review and Association Analysis With Next-Generation Sequencing.
    Gao F; Tian L; Shi H; Zheng P; Wang J; Dong F; Hu K; Ke X
    Front Genet; 2021; 12():677650. PubMed ID: 34925435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent Mutations in Refractory/Relapsed Diffuse Large B-Cell Lymphoma by Targeted Gene Sequencing.
    Sharma A; Das A; Bal A; Srinivasan R; Malhotra P; Prakash G; Kumar R
    Cytogenet Genome Res; 2023; 163(5-6):279-289. PubMed ID: 38071955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.
    Cani AK; Hovelson DH; Demirci H; Johnson MW; Tomlins SA; Rao RC
    Oncotarget; 2017 Jan; 8(5):7989-7998. PubMed ID: 28002793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic Mutation Profile of Primary Gastrointestinal Diffuse Large B-Cell Lymphoma.
    Li P; Chai J; Chen Z; Liu Y; Wei J; Liu Y; Zhao D; Ma J; Wang K; Li X; Shao Y; Gong L; Zhang W; Guo S; Yan Q; Li M; Fan L; Wang Z
    Front Oncol; 2021; 11():622648. PubMed ID: 33747936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaplastic Variant of Diffuse Large B-cell Lymphoma Displays Intricate Genetic Alterations and Distinct Biological Features.
    Li M; Liu Y; Wang Y; Chen G; Chen Q; Xiao H; Liu F; Qi C; Yu Z; Li X; Fan L; Guo Y; Yan Q; Guo S; Wang Z
    Am J Surg Pathol; 2017 Oct; 41(10):1322-1332. PubMed ID: 28319526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testicular large B-cell lymphoma is genetically similar to PCNSL and distinct from nodal DLBCL.
    Rivas-Delgado A; López C; Clot G; Nadeu F; Grau M; Frigola G; Bosch-Schips J; Radke J; Ishaque N; Alcoceba M; Tapia G; Luizaga L; Barcena C; Kelleher N; Villamor N; Baumann T; Muntañola A; Sancho-Cia JM; García-Sancho AM; Gonzalez-Barca E; Matutes E; Brito JA; Karube K; Salaverria I; Enjuanes A; Wiemann S; Heppner FL; Siebert R; Climent F; Campo E; Giné E; López-Guillermo A; Beà S
    Hemasphere; 2024 Oct; 8(10):e70024. PubMed ID: 39380845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mutational Spectrum and Prognosis Analysis of Young Patients with Diffuse Large B-Cell Lymphoma Based on Next-Generation Sequencing].
    Lyu LY; Nie YL; Renaguli A; Qi XL; Muhebaier A; Zhai SS; An L; Mao M; Li Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):403-410. PubMed ID: 37096512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Somatic Mutations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type by Massive Parallel Sequencing.
    Mareschal S; Pham-Ledard A; Viailly PJ; Dubois S; Bertrand P; Maingonnat C; Fontanilles M; Bohers E; Ruminy P; Tournier I; Courville P; Lenormand B; Duval AB; Andrieu E; Verneuil L; Vergier B; Tilly H; Joly P; Frebourg T; Beylot-Barry M; Merlio JP; Jardin F
    J Invest Dermatol; 2017 Sep; 137(9):1984-1994. PubMed ID: 28479318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic Alterations and MYD88
    Jiang S; Qin Y; Gui L; Liu P; Jiang H; Liu B; Yang J; Yang S; He X; Zhou S; Du X; Yi Y; Lin J; Shi Y
    Target Oncol; 2020 Apr; 15(2):221-230. PubMed ID: 32239385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Stability of Driver Alterations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type and Their Relapses: A Rationale for the Use of Molecular-Based Methods for More Effective Disease Monitoring.
    Schrader AMR; de Groen RAL; Willemze R; Jansen PM; Quint KD; Cleven AHG; van Wezel T; van Eijk R; Ruano D; Veelken JHH; Tensen CP; Neelis KJ; Daniels LA; Hauben E; Woei-A-Jin FJSHS; Busschots AMA; Vermeer MH; Vermaat JSP
    Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rare cases of primary central nervous system anaplastic variant of diffuse large B-cell lymphoma.
    Xu T; Jia Q; Wang Y; Liu Y; Han D; Li P; Ma J; Fan L; Yan Q; Guo S; Li M; Wang Z
    Diagn Pathol; 2019 May; 14(1):45. PubMed ID: 31109360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal evolution in relapsed and refractory diffuse large B-cell lymphoma is characterized by high dynamics of subclones.
    Melchardt T; Hufnagl C; Weinstock DM; Kopp N; Neureiter D; Tränkenschuh W; Hackl H; Weiss L; Rinnerthaler G; Hartmann TN; Greil R; Weigert O; Egle A
    Oncotarget; 2016 Aug; 7(32):51494-51502. PubMed ID: 27285986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole exome sequencing of relapsed/refractory patients expands the repertoire of somatic mutations in diffuse large B-cell lymphoma.
    Mareschal S; Dubois S; Viailly PJ; Bertrand P; Bohers E; Maingonnat C; Jaïs JP; Tesson B; Ruminy P; Peyrouze P; Copie-Bergman C; Fest T; Jo Molina T; Haioun C; Salles G; Tilly H; Lecroq T; Leroy K; Jardin F
    Genes Chromosomes Cancer; 2016 Mar; 55(3):251-67. PubMed ID: 26608593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lenalidomide in Pretreated Patients with Diffuse Large B-Cell Lymphoma: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice.
    Broccoli A; Casadei B; Chiappella A; Visco C; Tani M; Cascavilla N; Conconi A; Balzarotti M; Cox MC; Marino D; Goldaniga MC; Marasca R; Tecchio C; Patti C; Musuraca G; Devizzi L; Monaco F; Romano A; Fama A; Zancanella M; Paolini R; Rigacci L; Castellino C; Gaudio F; Argnani L; Zinzani PL
    Oncologist; 2019 Sep; 24(9):1246-1252. PubMed ID: 30940746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Mutation of
    Guo D; Hong L; Ji H; Jiang Y; Lu L; Wang X; Huang H
    J Inflamm Res; 2022; 15():1757-1769. PubMed ID: 35300216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.